-
Adam Brufsky, MD, PhD; University of Pittsburgh; 5Live #SABCS21
8:57
Key insights from the 2021 Annual Breast meeting in San Antonio
-
Matthew Ellis, MB, BChir, PhD, FRCP; Baylor College of Medicine; 5Live #SABCS21
5:47
Key insights from the 2021 Annual Breast meeting in San Antonio
-
Joanne Mortimer, MD; City of Hope: 5Live #SABCS21
5:20
Key insights from the 2021 Annual Breast meeting in San Antonio
-
Genomic assay in HR+/HER2- breast cancer; what we know and what we don't know_Kevin Kalinsky, MD, MS; #DDHO2021
4:29
-
Management of the axilla in breast cancer_Cletus Arciero, MD, FACS; #DDHO2021
2:04
-
Virginia Kaklamani, MD, DSc; UT Health San Antonio, MD Anderson Cancer Center; 5Live; #ASCO2021
5:04
-
Adam M. Brufsky, MD, PhD; UPMC Hillman Cancer Center University of Pittsburgh; 5Live; #ASCO2021
6:32
-
William J. Gradishar, MD, FASCO, FACP; Robert H. Lurie Comprehensive Cancer Center; 5Live; #ASCO2021
5:11
-
Optimizing Breast Cancer Care: The Patient Perspective_Julia Maues_Promo
0:45
-
Optimizing Breast Cancer Care: The Patient Perspective_Sheila McGlown_Promo
0:53
-
Disparities in Triple Negative Breast Cancer_Edith Mitchell, MD, MACP, FCPP, FRCP (London) & Lisa Newman, MD, MPH, FACS, FASCO, FSSO
39:24
- Next Page
ABOUT
Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
CONNECT
© Copyright 2021 Bio Ascend, a Vaniam Group company